Developer docs
API playgroundTry for free, no card

Search company profiles

Solabia Group

Full company profile

uuid003uagq

Namestring
Solabia Group
Legal namestring
SOLABIA SAS
Websiteurl
solabia.com
Company typeenum
Private
Founded yearint
1972
Descriptiontext

Solabia Group is a privately-held French biotechnology platform founded in 1972 and headquartered in Pantin, France, operating across five divisions: Cosmetics, Nutrition, Pharmaceuticals, Peptones & Hydrolysates, and BIOKAR Diagnostics. The company develops, produces, and distributes specialty ingredients, including active and functional cosmetic ingredients (61 actives, 33 functionals), botanical extracts from nearly 200 plant species, beauty pearls (SolaPearls, CrazySpheres), pharmaceutical-grade pidolates and chondroitin sulfate, peptones and hydrolysates for industrial fermentation, and more than 350 microbiological diagnostic products for culture media and alternative validated methods. Its underlying technology stack is built on fermentation, enzymatic biocatalysis and bioconversion, green chemistry (L-PCA), vegetal and marine extraction, and macro-inclusion, supported by 11 production sites and 7 R&D centers across France, Brazil, the United States, Israel, Germany, and the Netherlands.

Solabia generates revenue primarily through B2B ingredient sales to cosmetics manufacturers, pharmaceutical companies, nutraceutical brands, fermentation/cell culture industry players, and microbiological diagnostics laboratories in over 40 countries (cosmetics) and 50+ countries (via Mibelle Biochemistry). The company employs an enterprise sales model with direct subsidiaries in Brazil, the United States, and Germany, complemented by distributor networks across five continents. Pricing is quote-based and negotiated on multi-year contracts for enterprise customers, with no public list prices. Member-area portals serve each of the five divisions (Cosmetics, Pharma, Peptones, BIOKAR Diagnostics). In October 2025, the company was acquired by private equity firm Astorg in a €1.1 billion leveraged buyout alongside TA Associates, Téthys, and founder reinvestment, and subsequently completed three additional acquisitions in early 2026: Mibelle Biochemistry (Switzerland), Xebios Diagnostics Group (Germany/Netherlands), and Seqens' Botanical Actives and In-Vitro Diagnostics Activity (France).

The company's competitive position rests on a 50+ year track record, an extensive certification portfolio (ISO 9001, ISO 45001, ISO 17025, GMP Pharma, continuous Halal and Kosher certifications, COSMOS, RSPO, NF VALIDATION by AFNOR, EDQM), and a high innovation cadence evidenced by consecutive Double Gold Awards at In-Cosmetics Global in 2025 and 2026. Awards include ViscoPure (Best Functional) and OleoVeil Care (Make-up Bar) in 2026, alongside the Ecovadis Gold Medal for ESG performance in 2023. Recent strategic moves include a partnership with Interscience announced in April 2026 to integrate AI-powered colony counting into Biokar's microbiology workflow, marking a measured entry into AI-assisted diagnostics.

Short descriptiontext

Solabia Group is a French biotechnology platform founded in 1972 that develops and produces specialty ingredients for cosmetics, pharmaceuticals, nutrition, peptones, and microbiological diagnostics industries, serving enterprise customers in over 40 countries through direct sales and distributors.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
251–500
akta.pro rankint
HeadquartersCourbevoie, France
HQ citystring
Courbevoie
HQ countrystring
France
HQ regionstring
Europe
Markets served

Serves global market

Offices16 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
specialty cosmetic ingredients, biotechnology fermentation platform, pharmaceutical active ingredients, microbiological culture media, plant extract manufacturer
Industry2 codes
PRIMARYAFAJABAE
Agar, Carrageenan & Alginates (Seaweed Hydrocolloids)
Agriculture & Food Production/Food Ingredients & Additives/Starches & Hydrocolloids (Modified Starch, Gums, Thickeners)
SECONDARYAFABAEAM
Biological Formulation, Fermentation & Scale-Up Manufacturing
Agriculture & Food Production/Agricultural Inputs & Agrochemicals/Biologicals & Biopesticides (Microbials, Botanicals, Beneficial Insects)
NAICS code2 codes
  • Medicinal and Botanical Manufacturing325411
  • Biological Product (except Diagnostic) Manufacturing325414
SIC code2 codes
  • Medicinal Chemicals & Botanical Products2833
  • Industrial Organic Chemicals2860
Product category
Specialty Biotechnology Ingredients
Social media profiles2 records
GTM motion3 records

Each record includes

Type, Description, Source

Revenue model3 records
1B2B Ingredients Sales (Cosmetics, Pharma, Nutrition)
TypeOne Time License
Description

Solabia develops, produces and distributes raw material ingredients for cosmetics, pharmaceutical, nutrition and biotechnology industries. Revenue is generated through direct B2B sales of active ingredients, functional ingredients, plant extracts, beauty pearls, peptones, and culture media to manufacturers. Pricing is quote-based and typically negotiated on a per-contract basis for enterprise customers.

2Diagnostics Products and Culture Media
TypeOne Time License
Description

BIOKAR Diagnostics division generates revenue from sale of culture media, reagents, supplements and diagnostic kits to microbiology laboratories in food, pharmaceutical, cosmetics, and water testing industries. Products include over 350 catalog items in various formats.

solabia.com
3Cosmetic Active Ingredients for Leading Brands
TypeOne Time License
Description

Products commercialized worldwide to leading cosmetics brands, including botanical actives, biotech ingredients, and high-performance functional ingredients. Mibelle Biochemistry products distributed in over 50 countries.

klinegroup.com
Marketing channels8 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Personnel, Operations, Supply Chain, Technology or R&D, Marketing or Sales, Infrastructure
Pricing details1 tier
1B2B ingredients catalog — no public tier structure disclosed
ModelOtherBilling cadenceMulti-year contract
Notes

No public pricing tiers or list prices disclosed. Sales conducted through direct B2B engagement, member-area portals, and quote-based negotiation for enterprise customers across cosmetics, pharma, and diagnostics sectors.

GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 6 records shown
1Fucogel
Description

Universal and multifunctional cosmetic ingredient reference with active and sensory properties

solabia.com
+5 more records
Core offering1 text field

Solabia Group develops, produces, and distributes raw material ingredients for the cosmetics, pharmaceutical, nutraceutical, biotechnology, and microbiological diagnostics industries. Its portfolio spans active and functional cosmetic ingredients, plant and marine extracts, beauty pearls, pharmaceutical-grade pidolates and chondroitin sulfate, peptones and hydrolysates for fermentation, and culture media and diagnostic kits for industrial and clinical microbiology. The company operates 11 production sites and 7 R&D centers across France, Brazil, the United States, Israel, Germany, and the Netherlands.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 5 values shown
  • Biotechnology actives market estimated at over $800 million in 2025 with 3.9% CAGR, market size growth opportunity
+4 more records
Product overview1 text field

Solabia Group is a multi-sector biotechnology platform founded in 1972, operating across five divisions: Cosmetics, Nutrition, Pharma, Peptones & Hydrolysates, and BIOKAR Diagnostics. The company develops, produces, and distributes ingredients for cosmetics (active and functional ingredients, plant extracts, beauty pearls), pharmaceuticals (pidolates, chondroitin sulfate), nutrition, and microbiological diagnostics (culture media, reagents, microplates). The portfolio includes flagship products like Fucogel®, ViscoPure®, and OleoVeil® Care, complemented by acquired brands including Mibelle Biochemistry (PhytoCellTec™, SenoCellTec™), PolymerExpert, and multiple regional diagnostics companies. The company serves cosmetics, pharmaceutical, nutraceutical, food testing, and clinical diagnostics industries with operations spanning France, Brazil, USA, Germany, Netherlands, and Israel.

Product and service22 records
1Actives & Functional Cosmetic Ingredients
CategoryCosmetic Ingredients
2Plant Extracts
CategoryCosmetic Ingredients
3Fucogel
CategoryCosmetic Active Ingredient
4SolaPearls Beauty Pearls
CategoryCosmetic Delivery System
5ViscoPure
CategoryCosmetic Functional Ingredient
6OleoVeil Care
CategoryCosmetic Functional Ingredient
7Bloomlight
CategoryCosmetic Active Ingredient
8Pro-longevia
CategoryCosmetic Active Ingredient
9Serenibiome
CategoryCosmetic Active Ingredient
10BlueShield
CategoryCosmetic Active Ingredient
11Bioecolia
CategoryCosmetic Active Ingredient
12Applecare Pigment Dispersants (A-100 and PDS 300)
CategoryCosmetic Functional Ingredient
13PhytoCellTec Plant Stem Cell Ingredients
CategoryCosmetic Biotechnology Ingredient
14SenoCellTec Ingredient Technology
CategoryCosmetic Biotechnology Ingredient
15Pidolates (Calcium, Iron, Magnesium, Zinc)
CategoryPharmaceutical Active Ingredient
16Chondroitin Sulfate
CategoryPharmaceutical Active Ingredient
17L-Pidolic Acid
CategoryPharmaceutical Active Ingredient
18Peptones and Hydrolysates
CategoryFermentation Ingredients
19BIOKAR Culture Media and Diagnostic Products
CategoryMicrobiological Diagnostics
20Biokar Microplates (MUG/EC and MUD/SF)
CategoryMicrobiological Diagnostics
21IRIS Salmonella
CategoryMicrobiological Diagnostics
22PERFECTO Duo
CategoryMicrobiological Diagnostics
Scale indicator10 records

Each record includes

Type, Value, Description, Source

Partnership5 partners
Strategic tierCoreTypeTechnology or IntegrationAnnounced on2026-04-16
Description

Solabia and Interscience announced a strategic partnership to develop innovative solutions in microbiology. The partnership combines Biokar Diagnostics' expertise in culture media formulation and production with Interscience's equipment portfolio and AI-powered colony counting solutions (Scan AI, ScanStation). The collaboration aims to enhance traditional culture methods with artificial intelligence tools, delivering more efficient and reproducible results for industrial microbiology laboratories.

Strategic tierFlagshipTypeStrategic or Co-development PartnerAnnounced on2026-03-01
Description

Xebios Diagnostics Group, a leading microbiological diagnostics solution provider with operations in Germany and the Netherlands, was acquired by Solabia. Xebios specializes in diagnostic culture media and reagents for water, food, beverages, cosmetics, and clinical samples, operating three production sites with over 25 years of expertise.

3HFFIA (Halal Food & Feed Inspection Authority)
Strategic tierCoreTypeOthers
Description

HFFIA, based in The Hague, Netherlands, provides Halal certification for Solabia's peptone production facility in Beauvais, France. This partnership enables continuous Halal certification of plant peptones, an industry-first achievement allowing uninterrupted supply to Halal markets worldwide.

solabia.com
Strategic tierCoreTypeOthers
Description

The Orthodox Union's Kashruth division provides Kosher certification for Solabia's UCIB manufacturing site in Anet, France, and for various peptone products. This enables supply of Kosher-certified ingredients to markets requiring religious dietary compliance.

5Cosmetic Valley
Strategic tierMinorTypeStrategic or Co-development Partner
Description

BioEurope R&D center is an active member of Cosmetic Valley, participating in research programs with manufacturers, universities, and laboratories to advance understanding of biological skin mechanisms and active ingredient development.

solabia.com
Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

French in vitro diagnostics leader with major microbiology and industrial microbiology businesses. Directly comparable to Solabia's BIOKAR Diagnostics and newly acquired Xebios — same microbiology culture media foundations and similar French industrial-microbiology customer base.

TypeBroad incumbent
Description

German specialty ingredients group whose Scent & Care and Food & Beverage divisions include cosmetic actives, microalgae-derived ingredients (similar to Solabia's Algatech) and nutrition ingredients. Overlaps with Solabia's cosmetics, nutrition and microalgae businesses but at much larger scale.

TypeBroad incumbent
Description

UK-listed global specialty chemical company whose Personal Care division supplies bio-based and specialty actives to leading cosmetics brands. Much larger and broader than Solabia, but directly overlaps in cosmetic active ingredients, botanical extracts and biotech-derived conditioning actives.

TypeDirect peer
Description

Privately held French company specializing in botanical and biotech-derived active ingredients for the cosmetics industry. Closest direct competitor to Solabia's cosmetics division: same France-based specialty ingredient supplier model, similar biotech (fermentation, enzymatic) platform, and similar dependency on independent cosmetic brands for volume.

TypeBroad incumbent
Description

German specialty chemicals group whose Care Solutions and Specialty Additives lines include personal care actives, biotech-based ingredients and fermentation-derived specialty products. Competitor in cosmetic and industrial biotech actives, though Evonik's breadth extends well beyond Solabia's portfolio.

TypeBroad incumbent
Description

Swiss biotech manufacturer with a personal care business producing specialty actives, peptides and fermentation-derived ingredients. Overlaps with Solabia's biotech and peptone-derived ingredient capabilities, although Lonza operates across pharma, cell and gene therapy and many other adjacencies.

TypeBroad incumbent
Description

Swiss global leader in flavors, fragrances and active beauty ingredients. Its Active Beauty category competes head-on with Solabia's botanical and biotech cosmetic actives, but Givaudan operates across many more categories at a far greater scale.

TypeDirect peer
Description

Air Liquide subsidiary producing specialty ingredients for cosmetics, pharmaceuticals and nutrition, including excipients and actives. Direct overlap with Solabia's pharma excipient / cosmetic ingredient portfolio and a like-for-like French specialty ingredients competitor.

9Lucas Meyer Cosmetics (IFF)
TypeDirect peer
Description

IFF subsidiary focused on phospholipids, peptides and biotech-derived actives for skincare and makeup formulations. Direct overlap with Solabia's biotech active and functional ingredient portfolio, particularly in cosmetic delivery systems.

TypeBroad incumbent
Description

German chemicals major with a large Care Chemicals division producing cosmetic ingredients, actives and personal care specialties. Overlaps with Solabia's cosmetics division across multiple ingredient families but ships at vastly greater scale and geographic reach.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat6 records

Each record includes

Type, Details

Key risks7 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers4 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment5 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile5 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature9 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles2 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries15 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

Compliance11 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds1 record

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors1 record

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A8 records

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Solabia Group

Specialty Biotechnology Ingredientssolabia.com

Solabia Group is a French biotechnology platform founded in 1972 that develops and produces specialty ingredients for cosmetics, pharmaceuticals, nutrition, peptones, and microbiological diagnostics industries, serving enterprise customers in over 40 countries through direct sales and distributors.

What Solabia Group does

Solabia Group is a privately-held French biotechnology platform founded in 1972 and headquartered in Pantin, France, operating across five divisions: Cosmetics, Nutrition, Pharmaceuticals, Peptones & Hydrolysates, and BIOKAR Diagnostics. The company develops, produces, and distributes specialty ingredients, including active and functional cosmetic ingredients (61 actives, 33 functionals), botanical extracts from nearly 200 plant species, beauty pearls (SolaPearls, CrazySpheres), pharmaceutical-grade pidolates and chondroitin sulfate, peptones and hydrolysates for industrial fermentation, and more than 350 microbiological diagnostic products for culture media and alternative validated methods. Its underlying technology stack is built on fermentation, enzymatic biocatalysis and bioconversion, green chemistry (L-PCA), vegetal and marine extraction, and macro-inclusion, supported by 11 production sites and 7 R&D centers across France, Brazil, the United States, Israel, Germany, and the Netherlands.

Solabia generates revenue primarily through B2B ingredient sales to cosmetics manufacturers, pharmaceutical companies, nutraceutical brands, fermentation/cell culture industry players, and microbiological diagnostics laboratories in over 40 countries (cosmetics) and 50+ countries (via Mibelle Biochemistry). The company employs an enterprise sales model with direct subsidiaries in Brazil, the United States, and Germany, complemented by distributor networks across five continents. Pricing is quote-based and negotiated on multi-year contracts for enterprise customers, with no public list prices. Member-area portals serve each of the five divisions (Cosmetics, Pharma, Peptones, BIOKAR Diagnostics). In October 2025, the company was acquired by private equity firm Astorg in a €1.1 billion leveraged buyout alongside TA Associates, Téthys, and founder reinvestment, and subsequently completed three additional acquisitions in early 2026: Mibelle Biochemistry (Switzerland), Xebios Diagnostics Group (Germany/Netherlands), and Seqens' Botanical Actives and In-Vitro Diagnostics Activity (France).

The company's competitive position rests on a 50+ year track record, an extensive certification portfolio (ISO 9001, ISO 45001, ISO 17025, GMP Pharma, continuous Halal and Kosher certifications, COSMOS, RSPO, NF VALIDATION by AFNOR, EDQM), and a high innovation cadence evidenced by consecutive Double Gold Awards at In-Cosmetics Global in 2025 and 2026. Awards include ViscoPure (Best Functional) and OleoVeil Care (Make-up Bar) in 2026, alongside the Ecovadis Gold Medal for ESG performance in 2023. Recent strategic moves include a partnership with Interscience announced in April 2026 to integrate AI-powered colony counting into Biokar's microbiology workflow, marking a measured entry into AI-assisted diagnostics.

Solabia Group firmographics

Firmographics
Name
Solabia Group
Legal name
SOLABIA SAS
Website
https://solabia.com
Company type
Private
Founded year
1972
Operating status
Operating
Headcount range
251–500 employees
Short description
Solabia Group is a French biotechnology platform founded in 1972 that develops and produces specialty ingredients for cosmetics, pharmaceuticals, nutrition, peptones, and microbiological diagnostics industries, serving enterprise customers in over 40 countries through direct sales and distributors.
Ownership category
akta.pro rank

Solabia Group industry classification

Industry
Product category
Specialty Biotechnology Ingredients
NAICS
Medicinal and Botanical Manufacturing (325411), Biological Product (except Diagnostic) Manufacturing (325414)
SIC
Medicinal Chemicals & Botanical Products (2833), Industrial Organic Chemicals (2860)
akta.pro industry
PRIMARYAFAJABAE
Agar, Carrageenan & Alginates (Seaweed Hydrocolloids)
Agriculture & Food Production/Food Ingredients & Additives/Starches & Hydrocolloids (Modified Starch, Gums, Thickeners)
SECONDARYAFABAEAM
Biological Formulation, Fermentation & Scale-Up Manufacturing
Agriculture & Food Production/Agricultural Inputs & Agrochemicals/Biologicals & Biopesticides (Microbials, Botanicals, Beneficial Insects)

Keywords

  • Specialty cosmetic ingredients
  • Biotechnology fermentation platform
  • Pharmaceutical active ingredients
  • Microbiological culture media
  • Plant extract manufacturer

Where Solabia Group is headquartered

Location

Headquarters

HQ city
Courbevoie
HQ country
France
HQ region
Europe

Offices16 records

Markets served

Solabia Group business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Personnel, Operations, Supply Chain, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

  1. B2B Ingredients Sales (Cosmetics, Pharma, Nutrition): Solabia develops, produces and distributes raw material ingredients for cosmetics, pharmaceutical, nutrition and biotechnology industries. Revenue is generated through direct B2B sales of active ingredients, functional ingredients, plant extracts, beauty pearls, peptones, and culture media to manufacturers. Pricing is quote-based and typically negotiated on a per-contract basis for enterprise customers.
  2. Diagnostics Products and Culture Media: BIOKAR Diagnostics division generates revenue from sale of culture media, reagents, supplements and diagnostic kits to microbiology laboratories in food, pharmaceutical, cosmetics, and water testing industries. Products include over 350 catalog items in various formats.
  3. Cosmetic Active Ingredients for Leading Brands: Products commercialized worldwide to leading cosmetics brands, including botanical actives, biotech ingredients, and high-performance functional ingredients. Mibelle Biochemistry products distributed in over 50 countries.

Pricing tiers

ModelBillingPrice
OtherMulti-year contractB2B ingredients catalog — no public tier structure disclosed

Go-to-market motion3 records

Distribution channels3 records

Marketing channels8 records

Solabia Group product offering

Product offering

Core offering

Solabia Group develops, produces, and distributes raw material ingredients for the cosmetics, pharmaceutical, nutraceutical, biotechnology, and microbiological diagnostics industries. Its portfolio spans active and functional cosmetic ingredients, plant and marine extracts, beauty pearls, pharmaceutical-grade pidolates and chondroitin sulfate, peptones and hydrolysates for fermentation, and culture media and diagnostic kits for industrial and clinical microbiology. The company operates 11 production sites and 7 R&D centers across France, Brazil, the United States, Israel, Germany, and the Netherlands.

Product overview

Solabia Group is a multi-sector biotechnology platform founded in 1972, operating across five divisions: Cosmetics, Nutrition, Pharma, Peptones & Hydrolysates, and BIOKAR Diagnostics. The company develops, produces, and distributes ingredients for cosmetics (active and functional ingredients, plant extracts, beauty pearls), pharmaceuticals (pidolates, chondroitin sulfate), nutrition, and microbiological diagnostics (culture media, reagents, microplates). The portfolio includes flagship products like Fucogel®, ViscoPure®, and OleoVeil® Care, complemented by acquired brands including Mibelle Biochemistry (PhytoCellTec™, SenoCellTec™), PolymerExpert, and multiple regional diagnostics companies. The company serves cosmetics, pharmaceutical, nutraceutical, food testing, and clinical diagnostics industries with operations spanning France, Brazil, USA, Germany, Netherlands, and Israel.

Differentiator

Problem solved

Functional benefit

Brands

  • Fucogel: Universal and multifunctional cosmetic ingredient reference with active and sensory properties
  • SolaPearls
  • SolaPearls Active Color
  • CrazySpheres
  • ViscoPure
  • OleoVeil Care

Products and services

  • Actives & Functional Cosmetic Ingredients
  • Plant Extracts
  • Fucogel
  • SolaPearls Beauty Pearls
  • ViscoPure
  • OleoVeil Care
  • Bloomlight
  • Pro-longevia
  • Serenibiome
  • BlueShield
  • Bioecolia
  • Applecare Pigment Dispersants (A-100 and PDS 300)
  • PhytoCellTec Plant Stem Cell Ingredients
  • SenoCellTec Ingredient Technology
  • Pidolates (Calcium, Iron, Magnesium, Zinc)
  • Chondroitin Sulfate
  • L-Pidolic Acid
  • Peptones and Hydrolysates
  • BIOKAR Culture Media and Diagnostic Products
  • Biokar Microplates (MUG/EC and MUD/SF)
  • IRIS Salmonella
  • PERFECTO Duo

Quantifiable outcome

  • Biotechnology actives market estimated at over $800 million in 2025 with 3.9% CAGR, market size growth opportunity
  • +4 more outcomes

Companies that use Solabia Group

Customer profile

Named customers4 records

Segments5 records

Ideal customer profiles5 records

Solabia Group technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature9 records

Solabia Group partnerships and signals

Strategic signal

Partnerships

Five partnerships are on record, tiered core, flagship and minor.

  • IntersciencecoreTechnology or Integration · 16 April 2026Solabia and Interscience announced a strategic partnership to develop innovative solutions in microbiology. The partnership combines Biokar Diagnostics' expertise in culture media formulation and production with Interscience's equipment portfolio and AI-powered colony counting solutions (Scan AI, ScanStation). The collaboration aims to enhance traditional culture methods with artificial intelligence tools, delivering more efficient and reproducible results for industrial microbiology laboratories.
  • Xebios Diagnostics GroupflagshipStrategic or Co-development Partner · 1 March 2026Xebios Diagnostics Group, a leading microbiological diagnostics solution provider with operations in Germany and the Netherlands, was acquired by Solabia. Xebios specializes in diagnostic culture media and reagents for water, food, beverages, cosmetics, and clinical samples, operating three production sites with over 25 years of expertise.
  • HFFIA (Halal Food & Feed Inspection Authority)coreOthersHFFIA, based in The Hague, Netherlands, provides Halal certification for Solabia's peptone production facility in Beauvais, France. This partnership enables continuous Halal certification of plant peptones, an industry-first achievement allowing uninterrupted supply to Halal markets worldwide.
  • Orthodox Union (Kashruth Division)coreOthersThe Orthodox Union's Kashruth division provides Kosher certification for Solabia's UCIB manufacturing site in Anet, France, and for various peptone products. This enables supply of Kosher-certified ingredients to markets requiring religious dietary compliance.
  • Cosmetic ValleyminorStrategic or Co-development PartnerBioEurope R&D center is an active member of Cosmetic Valley, participating in research programs with manufacturers, universities, and laboratories to advance understanding of biological skin mechanisms and active ingredient development.

Scale indicators10 records

Recent moves6 records

Expansion highlights6 records

Solabia Group competitors and assessment

Company assessment

Direct peers

  • bioMérieux: French in vitro diagnostics leader with major microbiology and industrial microbiology businesses. Directly comparable to Solabia's BIOKAR Diagnostics and newly acquired Xebios — same microbiology culture media foundations and similar French industrial-microbiology customer base.
  • Silab: Privately held French company specializing in botanical and biotech-derived active ingredients for the cosmetics industry. Closest direct competitor to Solabia's cosmetics division: same France-based specialty ingredient supplier model, similar biotech (fermentation, enzymatic) platform, and similar dependency on independent cosmetic brands for volume.
  • Seppic (Air Liquide Healthcare Specialty Ingredients): Air Liquide subsidiary producing specialty ingredients for cosmetics, pharmaceuticals and nutrition, including excipients and actives. Direct overlap with Solabia's pharma excipient / cosmetic ingredient portfolio and a like-for-like French specialty ingredients competitor.
  • Lucas Meyer Cosmetics (IFF): IFF subsidiary focused on phospholipids, peptides and biotech-derived actives for skincare and makeup formulations. Direct overlap with Solabia's biotech active and functional ingredient portfolio, particularly in cosmetic delivery systems.

Broad incumbents

  • Symrise: German specialty ingredients group whose Scent & Care and Food & Beverage divisions include cosmetic actives, microalgae-derived ingredients (similar to Solabia's Algatech) and nutrition ingredients. Overlaps with Solabia's cosmetics, nutrition and microalgae businesses but at much larger scale.
  • Croda International: UK-listed global specialty chemical company whose Personal Care division supplies bio-based and specialty actives to leading cosmetics brands. Much larger and broader than Solabia, but directly overlaps in cosmetic active ingredients, botanical extracts and biotech-derived conditioning actives.
  • Evonik: German specialty chemicals group whose Care Solutions and Specialty Additives lines include personal care actives, biotech-based ingredients and fermentation-derived specialty products. Competitor in cosmetic and industrial biotech actives, though Evonik's breadth extends well beyond Solabia's portfolio.
  • Lonza Personal Care: Swiss biotech manufacturer with a personal care business producing specialty actives, peptides and fermentation-derived ingredients. Overlaps with Solabia's biotech and peptone-derived ingredient capabilities, although Lonza operates across pharma, cell and gene therapy and many other adjacencies.
  • Givaudan: Swiss global leader in flavors, fragrances and active beauty ingredients. Its Active Beauty category competes head-on with Solabia's botanical and biotech cosmetic actives, but Givaudan operates across many more categories at a far greater scale.
  • BASF Care Chemicals: German chemicals major with a large Care Chemicals division producing cosmetic ingredients, actives and personal care specialties. Overlaps with Solabia's cosmetics division across multiple ingredient families but ships at vastly greater scale and geographic reach.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks7 records

Key highlights7 records

Customer concentration

Solabia Group social profiles

Digital presence

Solabia Group compliance and trust

Trust signal

Compliance11 records

Solabia Group financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Solabia Group leadership team

Management profile

Number of profiles

Profiles2 records

Solabia Group subsidiaries and ownership

Company hierarchy

Subsidiaries15 records

Solabia Group funding detail

Funding detail

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Solabia Group M&A and investment

M&A and investment

M&A8 records

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Solabia Group

What does Solabia Group do?

Solabia Group develops, produces, and distributes raw material ingredients for the cosmetics, pharmaceutical, nutraceutical, biotechnology, and microbiological diagnostics industries. Its portfolio spans active and functional cosmetic ingredients, plant and marine extracts, beauty pearls, pharmaceutical-grade pidolates and chondroitin sulfate, peptones and hydrolysates for fermentation, and culture media and diagnostic kits for industrial and clinical microbiology. The company operates 11 production sites and 7 R&D centers across France, Brazil, the United States, Israel, Germany, and the Netherlands.

Is Solabia Group a public or private company?

Solabia Group is a private company. It is classified as private equity controlled and is currently operating.

When was Solabia Group founded?

Solabia Group was founded in 1972. It employs 251 to 500 people.

Where is Solabia Group based?

Solabia Group is headquartered in Courbevoie, France, in the Europe region.

How does Solabia Group make money?

Three revenue lines are on record. B2B Ingredients Sales (Cosmetics, Pharma, Nutrition) is the primary driver. The others are diagnostics Products and Culture Media and cosmetic Active Ingredients for Leading Brands.

Who are Solabia Group's main competitors?

Direct peers on record are bioMérieux, Silab, Seppic (Air Liquide Healthcare Specialty Ingredients) and Lucas Meyer Cosmetics (IFF). Broad incumbents are Symrise, Croda International, Evonik, Lonza Personal Care, Givaudan and BASF Care Chemicals.

Does Solabia Group have an API?

No public API is recorded for Solabia Group.

What industry is Solabia Group in?

Solabia Group's product category is Specialty Biotechnology Ingredients. Its primary akta.pro industry code is AFAJABAE, Agar, Carrageenan & Alginates (Seaweed Hydrocolloids), with a secondary code of AFABAEAM, Biological Formulation, Fermentation & Scale-Up Manufacturing. Its NAICS code is 325411 and its SIC code is 2833.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Dealroom.coSolabia takes majority stake in US nutraceutical maker Ethical Naturals | Dealroom NewsSolabia acquired a majority stake in US nutraceutical maker Ethical Naturals, with terms undisclosed. The deal gives Solabia an established US ingredient portfolio and customer base, while ENI gains access to Solabia's European network. Solabia plans to divest its microbiological diagnostics division and refocus on cosmetics, nutrition, and life sciences.Cosmetics BusinessSolabia appoints Muriel Koch as President and Chief Executive OfficerSolabia appointed Muriel Koch as President and CEO, effective 29 October 2026. She brings over 30 years of experience, previously leading NUXE and Nestlé. She will lead integration of Mibelle Biochemistry, acquired in June 2026.Global Cosmetics NewsSunday Business News: Supply SideThe global beauty and personal care supply chain is undergoing transformation, with consolidation, manufacturing pressures, and portfolio optimization as key themes. BASF explored a deal with Evonik, INEOS idled acetyls plants in Hull, and Solabia refocused on cosmetics and nutraceuticals. In 2026, success will depend on combining scientific innovation with operational resilience and strategic investment.Global Cosmetics NewsSolabia Refocuses on Cosmetics and Nutraceuticals as Muriel Koch Takes CEO RoleSolabia announced a strategic restructuring to focus on cosmetics, nutraceuticals, and biotechnology, appointing Muriel Koch as CEO on 29 October 2026. The company will divest its microbiology diagnostics division to Oxoid Remel Microbiology, following its acquisition of Mibelle Biochemistry in June 2026.EIN PresswireAstorg plans for Oxoid Remel to acquire Solabia’s microbiology diagnostics division | PE HubAstorg plans for Oxoid Remel to acquire Solabia's microbiology diagnostics division, which includes Biokar Diagnostics. The division focuses on microbiological culture media, particularly for food and beverage testing.SolabiaSolabia Group Welcomes Mibelle BiochemistrySolabia Group completed its acquisition of Mibelle Biochemistry from Persán, closing under terms announced on 19 February 2026. The deal strengthens Solabia's position in science-backed ingredients for beauty and wellbeing, combining Mibelle's plant stem cell technology with Solabia's international footprint. The combined portfolio will expand differentiated solutions for beauty and wellbeing markets.FortunebusinessinsightsMicroalgae-based food Market Size, Share & Report [2034]The global microalgae-based food market was valued at USD 743.75 million in 2025 and is projected to grow to USD 1,744.92 million by 2034, exhibiting a CAGR of 9.99% during the forecast period, driven by rising demand for sustainable and plant-based food alternatives amid challenges such as climate change and natural resource depletion. North America dominated the market with a 36.91% share in 2025, while Spirulina held the largest species segment share due to its exceptional protein content and nutritional value, with nutraceuticals accounting for 63.69% of application market share in 2026. Key players in the market include Archer Daniels Midland Company, BASF SE, DIC Corporation, and Solabia Group, which are focusing on technological advancements and strategic partnerships to expand their microalgae-based product portfolios.openPR.comFace Oils Market: In-Depth Examination of Product Segments, Trends, and Key CompetitorsDataM Intelligence published a market research report projecting the global Face Oils market to grow at a CAGR of 6.84% between 2024 and 2031, driven by rising demand for clean-label, multi-functional, and vegan skincare products. Multiple beauty companies across the United States and Japan launched new face oil products between December 2025 and March 2026, while strategic M&A activity — including Kindred Brands' acquisition of Kinship and Solabia Group's acquisition of Mibelle Biochemistry — reshaped the competitive landscape. Asia-Pacific is expected to dominate global demand due to expanding middle-class populations and strong skincare culture, while North America and Europe are led by premium personal care adoption and clean-label trends respectively.SolabiaXebios Diagnostics joins Solabia GroupSolabia announced the acquisition of Xebios Diagnostics Group, a leading microbiological diagnostics solution provider with operations in Germany and the Netherlands. Xebios specializes in diagnostic culture media and reagents for water, food, beverages, cosmetics, and clinical samples, operating three production sites and serving customers across the German and Benelux markets. The combination strengthens Solabia's manufacturing base across France, Germany, and the Netherlands while enhancing its innovation capacity and geographic reach in the European diagnostics market.